NXT Ventures

NXT Ventures focuses on identifying and supporting disruptive startup companies with the potential for cross-border synergies between the US and China. The firm typically invests in Seed and Series A rounds, with occasional participation in later stages such as Series B and beyond. Their investment strategy is geared towards helping startups scale domestically while also providing insights into international expansion, particularly in Asian markets.

Notable portfolio companies include Clinical Research IO, Intarcia Therapeutics, and Lionano. The firm is led by key partners with extensive experience in both venture capital and international markets, ensuring a robust network and strategic guidance for their portfolio companies. NXT Ventures emphasizes a collaborative approach, offering unique value-add services such as market entry strategies and cross-border partnership facilitation, which are crucial for startups aiming to expand globally.